Degenerative Cervical Leiomyoma Resembling Malignant Leiomyosarcoma
Marieke C. Punt1, Trudy G.N. Jonges2, Manon N. Braat3, Kartika Hapsari4, Henk W.R. Schreuder1,4*
1Department of Gynecology and
Reproductive Medicine, Division of Woman and Baby, University Medical Center
Utrecht, Netherlands
2Department of Pathology,
University Medical Center Utrecht, Netherlands
3Department of Radiology,
University Medical Center Utrecht, Netherlands
4Department of Gynecologic Oncology, UMC Utrecht Cancer Center, University Medical Centre Utrecht, Netherlands
*Corresponding author: Henk W.R. Schreuder, Department of Gynecologic Oncology, UMC Utrecht Cancer Center, University Medical Centre Utrecht, PO box 85500, 3508 GA Utrecht , The Netherlands. Tel: +310887556446; Email: H.W.R.Schreuder@umcutrecht.nl
Received Date: 04 March, 2018; Accepted Date: 25 April, 2018; Published Date: 30 April, 2018
Citation: Punt MC, Jonges TGN, Braat MN, Hapsari K, Schreuder HWR (2018) Degenerative Cervical Leiomyoma Resembling Malignant Leiomyosarcoma. J Surg 2018: 1112. DOI: 10.29011/2575-9760.001112
1. Case Report
A 65-year-old woman with no significant medical
history, other than a conisation of the cervix with unknown pathology in 1986,
presented to the Department of Gynecology with complaints of acute abdominal
pain and mucous vaginal discharge. Since, 2 weeks she has smelly, yellow
discharge and loss of energy. Abdominal examination revealed normal bowel
sounds and no significant palpable mass. Bi-manual vaginal Examination Under
Anesthesia (EUA) demonstrated a large (10 cm) round, elastic mass in the vagina
and douglas pouch. There was no palpable or visibly of the cervix and it was
not possible to perform a hysteroscopy or dilatation and curettage. Parametria
and uterosacral ligament did not appear to be infiltrated. Specimens, vaginal
culture and vaginal/cervical cytology revealed no malignant cells, yet a
nonspecific purulent infection was seen. Blood tests demonstrated elevated
leucocytes of 29 x109/L (normal
reference 10 x109/L, C-Reactive
Protein (CRP) of 112 mg/L (normal < 2 mg/L) and tumor marker CA-125 of 69
U/mL (normal <35 U/mL). Other tumor markers were within the normal range (CA-15.3,
CA-19.9 and CEA). CT-scan of the abdomen revealed a large mass (10.6 cm x 10.9
cm x 12.0 cm). This process likely originated from the cervix or proximal part
of the corpus of the uterus, and was suspect for a malignant leiomyosarcoma or
leiomyoma with degenerative changes. [1,2] Para-aortic
and iliac heterogeneous/necrotic lymphadenopathy (10 and 13 mm respectively)
was found. Since there was suspicion of a malignant leiomyosarcoma the patient
was referred to the University Hospital. An additional pelvic MRI showed an
infectious and necrotizing cervical mass protruding from the myometrium (Figure 1).
as well as enlarged, heterogeneous, possibly necrotic
obturator, common iliac and para-aortic lymph nodes, up to the level of the
renal veins. The differentiation between an infectious mass or a malignant mass
could not be made on radiology alone. However, the suspicion of a malignant
mass reduced after the MRI. The enlarged lymph nodes fit in both diagnosis.
Treatment: a median laparotomy was performed. There was no ascites and
peritoneal washings were taken. A hysterectomy with bilateral
salpingo-oophorectomy and excision of an enlarged lymph node was performed. At
pathology the uterus was cut in half and several purulent necrotizing areas
were found. (Figure 2). Final tissue cultures
did not show any bacteria. Cytology washings showed no malignant cells.
Histopathologic examination showed clearly a 13-cm
leiomyoma with extensive infection and multiple degenerative/necrotic parts.
There was no need to perform immunohistochemical examination. There were no
signs of malignancy (Figure 3).
In addition, an endometritis with pyometra was found. The enlarged lymph node showed reactive changes without any malignant cells. The woman recovered quickly, and no further follow-up was needed.
2. Learning Points
·
Differentiation between a leiomyoma with degenerative changes and a
leiomysarcoma can be difficult, MRI is preferred over CT.
·
A degenerative leiomyoma can present with large, heterogeneous
lymphadenopathy.
·
Degenerative leiomyoma can occur years after menopause.
· It's very important to reduce the time of uncertainty for a patient to a minimum.
3. Patient Perspective
The most debilitating effect of the initial diagnosis
(possibly cancer) just weeks before the day I would go into retirement, was the
total reorientation of our future lives that this seemed to imply for my
husband and myself; we had really looked forward to our lives as retirees and
those now appeared to be potentially very short-lived ones. All of that lies
behind me now, but the memory will undoubtedly stay. I appreciate the
professionalism, starting from the local hospital in my home town up to and
including the UMC Utrecht. The time waiting for the
final pathology results was initially too long and we had asked the
hospital to get the results before the weekend. This was unpleasant and gave us
a lot of extra distress. It's very important to reduce the time of uncertainty
for a patient to a minimum.
Figure 1: MRI - scan: A sagittal T2-weighted view showing a pedunculated mass
extending from the myometrium (arrow) and protruding into the vagina via a
seemingly completely effaced cervix.
Figure 2: Macroscopic findings: Multiple infectious and necrotic pockets within
the mass.
Figure 3: Microscopic view: extensive influx of the inflammatory cells. A) smooth muscle cells and B) inflammatory cells (Hematoxylin (HE) 250x).
- Arleo EK, Schwartz PE, Hui P, McCarthy S (2015) Review of Leiomyoma Variants. American Journal of Roentgenology 205: 912-921.
- AIp PP, Tse KY, Tam KF (2010) Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Anat Pathol 17: 91-112.
© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. Read More About Open Access Policy.